Purchase Order 75P00224P00031

Award Date 12/13/23
Potential Completion Date 12/29/23
Potential Value Not listed
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Beverly, MA 01915, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $231,000 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, on April 21, 2022. The contract is for the provision of inventory in support of the BioWatch program, a nationwide biosurveillance system to detect the intentional release of aerosolized biological agents. Qiagen Beverly, LLC, which does business as Qiagen Beverly Inc., is a subsidiary of the parent company Qiagen N.V. No...
The U.S. Department of Health and Human Services (HHS) awarded a $231,000.00 firm-fixed-price purchase order to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, to provide laboratory supplies in support of the BioWatch program. The BioWatch program is a nationwide biosurveillance system operated by HHS to detect the intentional release of aerosolized biological agents. This award is one of several contracts Qiagen Beverly, LLC has received from HHS to support the BioWatch...
The Department of Health and Human Services (HHS) awarded a Firm Fixed Price purchase order contract to Qiagen Beverly, LLC, a foreign-owned for-profit manufacturer, for $272,250.00 to provide BioWatch inventory. Qiagen Beverly, LLC has previously received other HHS awards to support the BioWatch program, a nationwide biosurveillance system to detect intentional release of biological agents. The contract does not have a set-aside designation. Additional details on the specific products or...
This federal contract award was made by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, for $231,990.00. The contract is for the provision of BioWatch inventory, which supports the BioWatch program, a nationwide biosurveillance system to detect the intentional release of aerosolized biological agents. This award did not have a set-aside designation. Qiagen Beverly, LLC is a...
This is a firm-fixed price purchase order awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a division of the parent company Qiagen N.V. The contract, valued at $165,155.23, is for the supply of laboratory supplies to support biosurveillance and COVID-19 testing efforts. Qiagen Beverly primarily provides products to the BioWatch program, a nationwide biosurveillance system operated by HHS to detect the intentional release of biological agents. The company has...
This $158,946.49 firm-fixed price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is for the provision of laboratory supplies, which are likely to support HHS's biosurveillance and COVID-19 testing efforts, such as the BioWatch program operated by HHS. Qiagen Beverly has received several previous awards from HHS and the Department of the Air Force to supply...
The Department of Health and Human Services (HHS) awarded a $331,000.00 Firm Fixed Price purchase order to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, for the provision of lab supplies. This award is not associated with any set-aside designation. Qiagen Beverly, LLC has previously received awards from HHS and the Department of the Air Force Materiel Command to provide products and services in support of the BioWatch program, a nationwide biosurveillance system to detect the...
This firm-fixed price purchase order was awarded by the U.S. Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, to provide laboratory supplies, testing components, and other products to support biosurveillance and COVID-19 testing efforts. The contract has a ceiling value of $165,918.73 and a completion date of March 12, 2018. It does not utilize any set-aside designations. Qiagen Beverly has received similar prime contracts from HHS...
The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded a $33,813 purchase order to Life Technologies Corporation for BIOWATCH INVENTORY. The firm fixed price contract has a period of performance from December 12, 2023 through December 22, 2023 for inventory services to be performed in Carlsbad, California. No subcontractors or set aside designations were identified. The award provides inventory support for the BioWatch program, a nationwide...
The Department of Health and Human Services awarded a $32,818 purchase order to Hi-Q Environmental Products Company of San Diego, California. The firm fixed price order is for BioWatch warehouse supplies to support the department's BioWatch program. Hi-Q will provide the supplies to the department from October 23, 2023 through November 22, 2023. No subcontractors or set aside designations were identified. The BioWatch program involves nationwide monitoring of air samples for early detection of...

The Department of Health and Human Services awarded a $243,600 firm fixed price purchase order to Qiagen Beverly, LLC for the BIOWATCH program. As the prime contractor, Qiagen Beverly will provide unspecified services or products to the Office of the Assistant Secretary for Administration in support of biosurveillance efforts. Performance will take place in Beverly, Massachusetts over a two week period concluding at the end of December 2023. No major subcontractors or set aside designations were identified. The award is likely associated with the BioWatch Generation 3 contract, an HHS program that operates a nationwide biosurveillance system to detect the intentional release of aerosolized biological agents.

Generated 12/24/23, 1:28 PM